Here is our slide deck from the 9th annual BIO Investor Forum in San Francisco:
BIO Investor Forum 2010 final
From the media and blogosphere:
Bloomberg
in vivo blog
Medical Technology Stock Letter
About the author
Senior Director of Industry Research & Policy Analysis at BIO covering investment, R&D and alliance deal trends as well as regulatory statistics that impact policy initiatives in Washington. Prior to joining BIO, David spent over a decade in the biotech industry as a biochemist in drug discovery at Amgen, Millennium and Novartis, and later in synthetic biology at the J Craig Venter Institute. David is also a financial analyst specializing in biotech rNPV and holds the Chartered Financial analyst (CFA) designation.
By Theresa Brady, February 12, 2019
By Rufael Seyum, February 11, 2019